Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China flag China · Delayed Price · Currency is CNY
32.81
-1.38 (-4.04%)
Jun 2, 2026, 3:00 PM CST

SHA:603590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
357.36332.57189.98230.2345.25599.08
Short-Term Investments
-136.3953.82183.820.7510.81
Trading Asset Securities
430.11500.43450.66396.41280.379.04
Cash & Short-Term Investments
787.47969.39694.46810.43626.36618.93
Cash Growth
30.60%39.59%-14.31%29.39%1.20%-59.49%
Accounts Receivable
275.14278.09257.38282.83296.39244.38
Other Receivables
76.0376.0733.8435.5627.736.31
Receivables
351.17354.16291.22318.39324.13250.69
Inventory
58.9654.4772.3848.4736.9947.02
Other Current Assets
112.4217.5128.4852.6729.2331.19
Total Current Assets
1,3231,3961,0871,2301,017947.83
Property, Plant & Equipment
397.8404.15426.73414.54440.14407.06
Long-Term Investments
47.611,0781,249984.45927.15695.95
Goodwill
---97.6497.6497.64
Other Intangible Assets
830.87833.37842.67854.64812.75815.17
Long-Term Deferred Tax Assets
16.8421.3627.4732.271.098.96
Long-Term Deferred Charges
319.26308234.36150.71120.4582.41
Other Long-Term Assets
1,14254.9153.3116.68.87316.3
Total Assets
4,0774,0953,9203,7813,4253,371
Accounts Payable
38.7731.273.5782.9748.4746.74
Accrued Expenses
23.5658.2745.6832.1526.8233.99
Short-Term Debt
266.16253.45140.9696.93--
Current Portion of Long-Term Debt
9.292.641.075.12--
Current Portion of Leases
-6.6173.958.717.5
Current Income Taxes Payable
7.740.714.690.2534.1215.84
Current Unearned Revenue
3.9255.956.436.492.921.2
Other Current Liabilities
84.3750.6273.2995.5351.3249.49
Total Current Liabilities
433.81459.45352.68323.39172.36154.77
Long-Term Debt
54.0154.2849.8543.78--
Long-Term Leases
1.463.1710.8-3.7111.12
Long-Term Unearned Revenue
40.5941.8740.4823.4928.9829.83
Long-Term Deferred Tax Liabilities
39.5439.7439.7227.7829.6245.02
Total Liabilities
569.41598.51493.52418.44234.68240.74
Common Stock
159.01159.01159.36160160160
Additional Paid-In Capital
949.82948.77944.6955.01992.46985.17
Retained Earnings
2,1622,1152,0452,0501,9311,876
Treasury Stock
-75.93-32.86-35.93-78.59-124.64-124.64
Comprehensive Income & Other
25.9321.1431.8-26.5-32.8-8.11
Total Common Equity
3,2213,2113,1443,0602,9262,889
Minority Interest
286.51285.21281.75302.44264.22241.81
Shareholders' Equity
3,5083,4963,4263,3623,1903,131
Total Liabilities & Equity
4,0774,0953,9203,7813,4253,371
Total Debt
330.92320.16209.67149.7812.4218.62
Net Cash (Debt)
456.56649.23484.79660.65613.94600.31
Net Cash Growth
21.25%33.92%-26.62%7.61%2.27%-60.08%
Net Cash Per Share
2.874.073.104.223.933.81
Filing Date Shares Outstanding
157.53157.53159.22158.98156.49156.49
Total Common Shares Outstanding
157.53158.61158.83158.98156.49156.49
Working Capital
888.84936.08733.86906.57844.35793.06
Book Value Per Share
20.4520.2519.8019.2518.7018.46
Tangible Book Value
2,3902,3782,3022,1082,0161,976
Tangible Book Value Per Share
15.1714.9914.4913.2612.8812.63
Buildings
-404.81324.61322.64323.38322.3
Machinery
-181.48126.83125.74126.76114.72
Construction In Progress
-81.73209.85190.8181.98127.26